{'fraction_non_alphanumeric': 0.04103671706263499, 'fraction_numerical': 0.0, 'mean_word_length': 5.72463768115942, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens

Intraductal carcinoma of the prostate (IDC‐P) is an adverse prognostic factor for radical prostatectomy (RP). The endpoint in most IDC‐P studies is increased prostate‐specific antigen (PSA) levels. The aim of this study was to evaluate whether IDC‐P in RP specimens is an adverse prognostic factor for progression‐free survival (PFS) and cancer‐specific survival (CSS).